Canada - English - Health Canada

kamada ltd - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums

Canada - English - Health Canada

grifols therapeutics llc - rabies immunoglobulin (human) - solution - 300unit - rabies immunoglobulin (human) 300unit - serums

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur - inactivated rabies virus strain pm/wi 38 1503 3m - powder and solvent for suspension for injection - 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

Canada - English - Health Canada

cutter med & biol, division of miles canada ltd. - rabies immunoglobulin (human) - liquid - 16.5% - rabies immunoglobulin (human) 16.5% - serums

Canada - English - Health Canada

pasteur mÉrieux serums et vaccins, s.a. - rabies immunoglobulin (human) - liquid - 150unit - rabies immunoglobulin (human) 150unit - serums

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - rabies immunoglobulin - solution for injection - rabies immunoglobulin 150 iu/ml - rabies immunoglobulin - rabies immunoglobulin - to be given in conjunction with rabies vaccine as promptly as possible after exposure.

Kenya - English - Pharmacy and Poisons Board

human bioplazma llc h-2100 godollo transics milhaly ut 80hungary - human albumin - solution for infusion - 20%human albumin - blood substitutes and plasma protein fractions

Canada - English - Health Canada

grifols therapeutics llc - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums

United States - English - NLM (National Library of Medicine)

grifols usa, llc - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 0.165 g in 1 ml - gamastan is a human immune globulin indicated for: gamastan is indicated for prophylaxis following exposure to hepatitis a.(1,2) the prophylactic value of gamastan is greatest when given before or soon after exposure to hepatitis a. gamastan is not indicated in persons with clinical manifestations of hepatitis a or in those exposed more than 2 weeks previously. gamastan is indicated to prevent or modify measles in a susceptible person exposed fewer than 6 days previously.(3) a susceptible person is one who has not been vaccinated and has not had measles previously. - gamastan may be especially indicated for susceptible household contacts of measles patients, particularly contacts under 1 year of age, for whom the risk of complications is highest.(3) - gamastan is also indicated for pregnant women without evidence of immunity. - do not give gamastan and measles vaccine at the same time. if a child is older than 12 months and has received gamastan, give measles vaccine about five months later when the measles a

Australia - English - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - normal immunoglobulin, quantity: 10 mg/ml - injection - excipient ingredients: glycine; water for injections - replacement therapy in: - primary immunodeficiency (pi) diseases; - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation in: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - guillain barr? syndrome (gbs); - chronic inflammatory demyelinating polyneuropathy (cidp); - kawasaki disease.